A resource to keep Wirral University Teaching Hospital (WUTH) and Wirral Community Health and Care Trust (WCHCT) staff and students on placement up to date with the latest developments, news and events relating to library, research and evidence based practice within the organisation. Brought to you as a collaborative venture between the Library & Knowledge Service and the WUTH Research & Development department.
Tracking
Friday, 25 September 2020
CCC publication: 611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476),
CCC publication: PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
Wednesday, 23 September 2020
WUTH publication: Non-anaemic iron deficiency should be investigated with the same priority as iron deficiency anaemia in fast track colorectal clinics-retrospective cohort study
WUTH publication: Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease
Citation: Alimentary pharmacology and therapeutics. 2020, 52(8), 1341-52
Author: Townsend T, Razanskaite V, Dodd S, Storey D, Michail S, Morgan J, Davies M, Penman D, Watters C, Swaminathan M, Sabine J, Chapman A, Smith PJ, Flanagan PK, Reilly I, Bodger K, Subramanian S
Abstract: Background: Anti-tumour necrosis factor (TNF) agents are effective in Crohn's disease but some patients lose response and require alternative biologic therapy. There are few data on comparative effectiveness of vedolizumab and ustekinumab in this setting.
Aim: To compare the effectiveness of ustekinumab and vedolizumab in anti-TNF-refractory Crohn's disease over 12 months.
Methods: Patients commencing ustekinumab or vedolizumab for anti-TNF-refractory Crohn's disease with minimum follow-up of 12 months were included. The primary outcome measure was the difference in steroid-free remission rates at end of induction (2 months) and at 12 months. We also assessed rates of clinical response and remission, treatment persistence, surgery and adverse events in both groups. We performed logistic regression analysis to assess factors associated with steroid-free remission and clinical response and remission.
Results: We included 85 patients commencing vedolizumab and 45 commencing ustekinumab. In an unadjusted model, rates of steroid-free and clinical remission were significantly higher among ustekinumab-treated patients. After adjusting for confounders, steroid-free remission was higher among ustekinumab-treated patients at 2 months (odds ratio, OR 2.79, 95% confidence interval, CI 1.06-7.39, P = 0.038) and 12 months (OR 2.01, 95% CI 0.89-4.56, P = 0.095). More patients treated with ustekinumab remained on therapy at the end of 12 months (84.4% vs 61.5%, P = 0.007).
Conclusions: Ustekinumab appeared more effective in treating anti-TNF-refractory Crohn's disease and more patients persisted with therapy.
Friday, 18 September 2020
WUTH publication: Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
WUTH publication: The Central Role and Possible Mechanisms of Bacterial DNAs in Sepsis Development
WUTH publication: An audit of process and outcome for emergency colectomy in England and Wales
Monday, 14 September 2020
WUTH publication: Tax-otsubo': stress cardiomyopathy following an encounter with the Inland Revenue
Citation: BMJ Case Reports. 2020, 13(1), e232225
Author: Roach MW, Currie P
Abstract: An 89-year-old man developed chest pain and palpitations shortly after finishing a stressful 40 min phone call to HM Revenue and Customs. After admission to the emergency department, he had a cardiovascular collapse followed soon after by a cardiac arrest due to ventricular fibrillation (VF). The troponin T was elevated and his ECG showed extensive deep T wave inversion with prolongation of the QT interval. A portable hand-held ultrasound device (VScan; GE Healthcare) was used to demonstrate classical apical ballooning of the left ventricular apex indicating a diagnosis of takotsubo stress cardiomyopathy. Shortly following admission to the cardiac care unit, he had a further episode of VF, which was successfully defibrillated. A coronary angiogram was performed, which was normal. He was treated with a short course of benzodiazepines. He was discharged after 8 days without any neurological deficit. His echocardiogram subsequently showed complete resolution of the abnormalities of the left ventricular function.
Keywords: arrhythmias; clinical diagnostic tests; heart failure.
Wednesday, 2 September 2020
WUTH publication: Reply to "Fluoroscopy during coccygectomy for rectal cancer"
Author: Simpson G, Marks T, Blacker S, Smith D, Walsh C
WUTH publication: Legacy of COVID-19 - the opportunity to enhance surgical services for patients with colorectal disease
Author: Arulampalam T, Bhangu A, Brown SR, Clark SK, Din F, Harji D, Knowles CH, McNamara D, Moug SJ, Smart N, Tierney G, Torkington J, Walsh C, Watson A, Fearnhead NS
Abstract: The COVID-19 crisis has undoubtedly taken a toll on the care of patients with colorectal disease. Elective services, be that face to face contact, endoscopy or operating all but ceased during the pandemic.